Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis

van Engelen, B G; Miller, D J; Pavelko, K D; Hommes, O R; Rodriguez, M
November 1994
Journal of Neurology, Neurosurgery & Psychiatry;Nov1994 Supp, Vol. 57, p65
Academic Journal
journal article
No abstract available.


Related Articles

  • Promotion of Remyelination by Immunoglobulins: Implications for the Treatment of Multiple Sclerosis. Trebst, C.; Stangel, M. // Current Pharmaceutical Design;Jan2006, Vol. 12 Issue 2, p241 

    During the last decade immunomodulatory treatments have been shown to influence the natural course of multiple sclerosis (MS). However, demyelination in the central nervous system (CNS) still occurs and repair mechanisms are incomplete leading to neurological deficits. Currently, there is no...

  • Hematopoietic Stem Cell Therapy for Multiple Sclerosis. Burt, Richard K. // Multiple Sclerosis (13524585);Dec2000, Vol. 6 Issue 6, p415 

    Investigates the safety and efficacy of hematopoietic stem cell transplantation therapy in animal models of multiple sclerosis. Procedures involved in inducing experimental autoimmune encephalomyelitis (EAE) on animal models; Pathogenic processes involved in both EAE and Theiler's murine...

  • CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesions. Trebst, C.; K�nig, F.; Ransohoff, R. M.; Br�ck, W.; Stangel, M. // Multiple Sclerosis (13524585);Jul2008, Vol. 14 Issue 6, p728 

    Remyelination in multiple sclerosis (MS) occurs spontaneously and extensively. The underlying mechanisms, however, are only partly understood. Findings in experimental animal settings suggest that inflammation promotes remyelination and repair. Here, we characterized the chemokine receptor...

  • A unique population of circulating autoantibodies promotes central nervous system remyelination. Asakura, K.; Rodriguez, M. // Multiple Sclerosis (13524585);Jun98, Vol. 4 Issue 3, p217 

    In previous studies we demonstrated that the humoral immune response directed against unique central nervous system (CNS) antigens enhanced CNS remyelination in the Theiler's virus experimental model of multiple sclerosis (MS). To expand on this observation, a mouse IgMκ monoclonal antibody...

  • Downregulating DR6 to drive remyelination. Popko, Brian // Nature Medicine;Jul2011, Vol. 17 Issue 7, p779 

    To repair the immune-mediated demyelination that occurs in people with multiple sclerosis, strategies to enhance remyelination are being considered as a possible therapy. A new study shows that inhibition of death receptor 6 (DR6) signaling increases the maturation and survival of...

  • Remyelination Induced by a DNA Aptamer in a Mouse Model of Multiple Sclerosis. Nastasijevic, Branislav; Wright, Brent R.; Smestad, John; Warrington, Arthur E.; Rodriguez, Moses; Maher, III, L. James // PLoS ONE;Jun2012, Vol. 7 Issue 6, p1 

    Multiple sclerosis (MS) is a debilitating inflammatory disease of the central nervous system (CNS) characterized by local destruction of the insulating myelin surrounding neuronal axons. With more than 200 million MS patients worldwide, the absence of treatments that prevent progression or...

  • The biology of CNS remyelination. Franklin, Robin J. M.; Kotter, Mark R. // Journal of Neurology;Jan2008 Supplement 1, Vol. 255, p19 

    Remyelination, the process by which new myelin sheaths are restored to demyelinated axons, represents one of the most compelling examples of adult multipotent progenitor cells contributing to regeneration of the injured CNS. This process can occur with remarkable efficiency in both clinical...

  • Fibronectin aggregation in multiple sclerosis lesions impairs remyelination. Stoffels, Josephine M. J.; de Jonge, Jenny C.; Stancic, Mirjana; Nomden, Anita; van Strien, Miriam E.; Ma, Dan; Šišková, Zuzana; Maier, Olaf; ffrench-Constant, Charles; Franklin, Robin J. M.; Hoekstra, Dick; Zhao, Chao; Baron, Wia // Brain: A Journal of Neurology;Jan2013, Vol. 136 Issue 1, p116 

    Remyelination following central nervous system demyelination is essential to prevent axon degeneration. However, remyelination ultimately fails in demyelinating diseases such as multiple sclerosis. This failure of remyelination is likely mediated by many factors, including changes in the...

  • Catalpol induces oligodendrocyte precursor cell-mediated remyelination in vitro. Chun-Xiao Yuan; Takho Chu; Li Liu; Hao-Wen Li; Ya-Jie Wang; An-Chen Guo; Yong-Ping Fan // American Journal of Translational Research;2015, Vol. 7 Issue 11, p2474 

    In demyelinating diseases such as multiple sclerosis, one of the treatment strategies includes remyelination using oligodendrocyte precursor cells (OPC). Catalpol, the extract of radix rehmanniae, is neuroprotective. Using an OPC culture model, we showed that 10 µM catalpol promotes OPC...

  • Signalling Pathways that Inhibit the Capacity of Precursor Cells for Myelin Repair. Sabo, Jennifer K.; Cate, Holly S. // International Journal of Molecular Sciences;Jan2013, Vol. 14 Issue 1, p1031 

    In demyelinating disorders such as Multiple Sclerosis (MS), targets of injury are myelin and oligodendrocytes, leading to severe neurological dysfunction. Regenerative therapies aimed at promoting oligodendrocyte maturation and remyelination are promising strategies for treatment in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics